Related Experiment Video

Updated: Oct 5, 2026

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

Cancer therapies: basic and clinical perspectives in brain, prostate, and lung tumors: Naples, September, 24-27, 2000

G G Giordano1, M Muto, L Sigalotti

  • 1Istituto di Anatomia Patologica, Facoltà di Medicina, II Università di Napoli, Naples, Italy. giacomogiordano@libero.it

Journal of Cellular Physiology
|June 26, 2001
PubMed

Insights

This conference united cancer researchers and clinicians to share advancements in brain, prostate, and lung cancer therapies. The focus was on integrating basic research with clinical practice for improved cancer treatment strategies.

Area of Science:

  • Oncology
  • Translational Cancer Research
  • Medical Science

Background:

  • Effective cancer treatment requires seamless integration of basic research, diagnostics, and therapeutic innovation.
  • Progress in oncology relies on continuous information exchange between laboratory findings and clinical applications.
  • Human cancer remains a significant global health challenge necessitating collaborative scientific efforts.

Framework:

  • The Fourth Joint International Cancer Conference convened leading basic scientists and clinicians.
  • The conference aimed to bridge the gap between fundamental research and clinical practice in oncology.
  • Key focus areas included brain, prostate, and lung cancer.

Implementation:

  • Discussions centered on the latest scientific achievements in basic and clinical cancer research.
  • Advanced diagnostic strategies for brain, prostate, and lung cancers were presented.
  • Novel therapeutic strategies, including molecular and cellular approaches, were explored.

Implications:

  • Fostering collaboration accelerates the development of effective cancer therapies.
  • Sharing cutting-edge research facilitates timely clinical translation and improved patient outcomes.
  • Advancements in understanding and treating brain, prostate, and lung cancers are anticipated.

More Related Videos

Method for Novel Anti-Cancer Drug Development using Tumor Explants of Surgical Specimens09:26

Method for Novel Anti-Cancer Drug Development using Tumor Explants of Surgical Specimens

Published on: July 29, 2011

Modeling Brain Metastasis by Internal Carotid Artery Injection of Cancer Cells10:01

Modeling Brain Metastasis by Internal Carotid Artery Injection of Cancer Cells

Published on: August 2, 2022

Related Concept Videos

Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Cancer02:18

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.